NASDAQ:INCR InterCure Q2 2025 Earnings Report $5.30 -0.02 (-0.28%) Closing price 09/18/2026 03:59 PM EasternExtended Trading$5.32 +0.03 (+0.55%) As of 09/18/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast InterCure EPS ResultsActual EPS-$0.08Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AInterCure Revenue ResultsActual Revenue$19.25 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AInterCure Announcement DetailsQuarterQ2 2025Date10/8/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile InterCure Earnings HeadlinesInterCure Regains Nasdaq Compliance After Delisting WarningSeptember 8, 2026 | tipranks.comInterCure Regains Compliance with Nasdaq Minimum Bid Price RequirementSeptember 8, 2026 | globenewswire.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.September 19 at 1:00 AM | The Oxford Club (Ad)InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?August 27, 2026 | insidermonkey.comInterCure Raises $5 Million in August Private Placement to Rebuild Nir Oz FacilityAugust 26, 2026 | tipranks.comInterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect DamagesAugust 24, 2026 | globenewswire.comSee More InterCure Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like InterCure? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InterCure and other key companies, straight to your email. Email Address About InterCureInterCure (NASDAQ:INCR) is an Israeli medical cannabis company that operates through its Canndoc subsidiary. The company is involved in the cultivation, production, distribution and sale of medical cannabis products, serving patients through pharmacies, clinics and other authorized channels. Its product portfolio includes cannabis flower, oils and other medical cannabis formulations. InterCure has developed a vertically integrated business model that spans cultivation and manufacturing as well as wholesale and retail distribution, with operations primarily focused on Israel. InterCure has also pursued international expansion through partnerships, licensing arrangements and commercial activities in selected overseas markets, subject to local cannabis regulations. The company’s shares trade on the Nasdaq under the symbol INCR and on the Tel Aviv Stock Exchange.View InterCure ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the LimitsCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
